BioSpace News Archive

Thermo Fisher Scientific today unveiled the Thermo Scientific Axia ChemiSEM, a cost-effective, floor-model scanning electron microscope (SEM) that takes materials micro-structural analysis and defect discovery to a new level of speed and simplicity.

Glympse Bio (Glympse), a biotechnology company advancing the way diseases are understood, tracked, and treated, today announced that it will present clinical safety data from its First in Human healthy volunteer study, and data from a gene expression study of patients with advanced fibrosis at the American Association for the Study of Liver Disease (AASLD) 2020 Annual Meeting

Seneca Biopharma, Inc. (Nasdaq: SNCA), a biopharmaceutical company focused on developing novel treatments for diseases of high unmet medical need, today reported its financial results for the quarter ended September 30, 2020.

Market Uptake Growing with Manufacturers Ranging from Big Pharma and Mid-Tier to Emerging

Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with kidney and cardiovascular diseases, today announced that Mike Raab , president and chief executive officer of Ardelyx, will participate in a fireside chat at the Jefferies Virtu

Medikine, Inc., a preclinical-stage biopharmaceutical company developing innovative peptide-based agonists of cytokine receptors relevant to cancer treatment, today announced that it will deliver three poster presentations at the 35th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2020),

Products Include Artisanal Pasta and Wheat Flour; Filling a Need in the Market for High Fiber, Low-Calorie Cooking and Baking Ingredients

Indivumed announced today the launch of its new, AI-integrated Advanced Data Analytics Platform which will accelerate drug targets and diagnostics discoveries.

Genosity, Inc., an innovative biotechnology company that provides comprehensive software and laboratory solutions to enable precision medicine, announced today that it has entered into a strategic collaboration agreement with Igentify,

Boston Children’s Hospital, which has the largest National Institutes of Health-funded pediatric research enterprise in the United States, and Deerfield Management Company, a healthcare investment firm, announced a major research collaboration to advance promising therapeutics that will address unsolved medical needs and find cures for disease.